{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,4]],"date-time":"2026-09-04T17:53:07Z","timestamp":1788544387744,"version":"build-2803163510"},"reference-count":105,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2015,1,1]],"date-time":"2015-01-01T00:00:00Z","timestamp":1420070400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2014,5,23]],"date-time":"2014-05-23T00:00:00Z","timestamp":1400803200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/3.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Saudi Journal of Biological Sciences"],"published-print":{"date-parts":[[2015,1]]},"DOI":"10.1016\/j.sjbs.2014.05.003","type":"journal-article","created":{"date-parts":[[2014,5,23]],"date-time":"2014-05-23T07:17:36Z","timestamp":1400829456000},"page":"4-13","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":61,"title":["Alzheimer\u2019s disease and type 2 diabetes via chronic inflammatory mechanisms"],"prefix":"10.1016","volume":"22","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4880-4035","authenticated-orcid":false,"given":"Gohar","family":"Mushtaq","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jalaluddin A.","family":"Khan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Taha A.","family":"Kumosani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammad A.","family":"Kamal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.sjbs.2014.05.003_b0005","doi-asserted-by":"crossref","first-page":"1050","DOI":"10.1212\/WNL.58.7.1050","article-title":"Randomized pilot study of nimesulide treatment in Alzheimer\u2019s disease","volume":"58","author":"Aisen","year":"2002","journal-title":"Neurology"},{"key":"10.1016\/j.sjbs.2014.05.003_b0010","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1016\/S0197-4580(00)00124-X","article-title":"Inflammation and Alzheimer\u2019s disease","volume":"21","author":"Akayama","year":"2000","journal-title":"Neurobiol. Aging"},{"issue":"3","key":"10.1016\/j.sjbs.2014.05.003_b0015","doi-asserted-by":"crossref","first-page":"467","DOI":"10.2174\/18715273113126660153","article-title":"Alzheimer\u2019s disease and type 2 diabetes mellitus: the link to tyrosine hydroxylase and probable nutritional strategies","volume":"13","author":"Aliev","year":"2014","journal-title":"CNS Neurol. Disord. Drug Targets"},{"issue":"5","key":"10.1016\/j.sjbs.2014.05.003_b0020","first-page":"448","article-title":"Do angiotensin converting enzyme inhibitors or angiotensin receptor blockers prevent diabetes mellitus? A meta-analysis","volume":"17","author":"Al-Mallah","year":"2010","journal-title":"Cardiol. J."},{"issue":"5","key":"10.1016\/j.sjbs.2014.05.003_b0025","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1001\/archneur.61.5.661","article-title":"Diabetes mellitus and risk of Alzheimer disease and decline in cognitive function","volume":"61","author":"Arvanitakis","year":"2004","journal-title":"Arch. Neurol."},{"issue":"4","key":"10.1016\/j.sjbs.2014.05.003_b0030","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1111\/j.1600-0404.1990.tb01563.x","article-title":"Blood\u2013brain barrier disturbance in patients with Alzheimer\u2019s diseases related to vascular factors","volume":"81","author":"Blennow","year":"1990","journal-title":"Acta Neurol. Scand."},{"key":"10.1016\/j.sjbs.2014.05.003_b0035","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/S0197-4580(99)00110-4","article-title":"Vascular risk factors for Alzheimer\u2019s disease: an epidemiologic perspective","volume":"21","author":"Breteler","year":"2000","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.sjbs.2014.05.003_b0040","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/S0889-8561(02)00056-5","article-title":"Age-related inflammatory cytokines and disease","volume":"23","author":"Bruunsgaard","year":"2003","journal-title":"Immunol. Allergy Clin. North Am."},{"key":"10.1016\/j.sjbs.2014.05.003_b0045","doi-asserted-by":"crossref","first-page":"M357","DOI":"10.1093\/gerona\/54.7.M357","article-title":"A high plasma concentration of TNF-alpha is associated with dementia in centenarians","volume":"54","author":"Bruunsgaard","year":"1999","journal-title":"J. Gerontol. A Biol. Sci. Med. Sci."},{"key":"10.1016\/j.sjbs.2014.05.003_b0050","doi-asserted-by":"crossref","first-page":"2796","DOI":"10.2337\/diabetes.51.9.2796","article-title":"Preservation of pancreatic beta-cell function and prevention of type 2 diabetes by pharmacological treatment of insulin resistance in high-risk Hispanic women","volume":"51","author":"Buchanan","year":"2002","journal-title":"Diabetes"},{"key":"10.1016\/j.sjbs.2014.05.003_b0055","unstructured":"Centers for Disease Control and Prevention [CDC], 2006. Diabetes data and trends [online]. URL: <http:\/\/www.cdc.gov\/diabetes\/statistics>."},{"key":"10.1016\/j.sjbs.2014.05.003_b0060","doi-asserted-by":"crossref","first-page":"542","DOI":"10.2337\/diacare.25.3.542","article-title":"Differential effects of metformin and troglitazone on cardiovascular risk factors in patients with type 2 diabetes","volume":"25","author":"Chu","year":"2002","journal-title":"Diabetes Care"},{"issue":"2","key":"10.1016\/j.sjbs.2014.05.003_b0065","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1523\/JNEUROSCI.20-02-00558.2000","article-title":"Inflammatory mechanisms in Alzheimer\u2019s disease: inhibition of \u03b2-amyloid-stimulated proinflammatory responses and neurotoxicity by PPARg agonists","volume":"20","author":"Combs","year":"2000","journal-title":"J. Neurosci."},{"key":"10.1016\/j.sjbs.2014.05.003_b0070","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1016\/S0002-9610(01)00822-4","article-title":"Inflammation","volume":"182","author":"Cone","year":"2001","journal-title":"Am. J. Surg."},{"issue":"2","key":"10.1016\/j.sjbs.2014.05.003_b0075","doi-asserted-by":"crossref","first-page":"271","DOI":"10.2174\/18715273113126660134","article-title":"Fighting Alzheimer\u2019s disease and type 2 diabetes: pathological links and treatment strategies","volume":"13","author":"Dai","year":"2014","journal-title":"CNS Neurol. Disord. Drug Targets"},{"key":"10.1016\/j.sjbs.2014.05.003_b0330","doi-asserted-by":"crossref","unstructured":"de Oliveira, F.F., Bertolucci, P.H., Chen, E.S., Smith, M.C., 2014. Brain-penetrating angiotensin-converting enzyme inhibitors and cognitive change in patients with dementia due to Alzheimer\u2019s disease. J. Alzheimers Dis. <http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/24577465>.","DOI":"10.3233\/JAD-132189"},{"key":"10.1016\/j.sjbs.2014.05.003_b0080","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1038\/nm890","article-title":"RAGE mediates amyloid-beta peptide transport across the blood-brain barrier and accumulation in brain","volume":"9","author":"Deane","year":"2003","journal-title":"Nat. Med."},{"key":"10.1016\/j.sjbs.2014.05.003_b0085","doi-asserted-by":"crossref","first-page":"2305","DOI":"10.2337\/diabetes.54.8.2305","article-title":"Expression of CD68 and macrophage chemoattractant protein-1 genes in human adipose and muscle tissues: association with cytokine expression, insulin resistance, and reduction by pioglitazone","volume":"54","author":"Di Gregorio","year":"2005","journal-title":"Diabetes"},{"key":"10.1016\/j.sjbs.2014.05.003_b0090","doi-asserted-by":"crossref","first-page":"2922","DOI":"10.1161\/01.STR.0000099124.84425.BB","article-title":"Angiotensin-converting enzyme inhibitor use is associated with reduced plasma concentration of C-reactive protein in patients with first-ever ischemic stroke","volume":"34","author":"Di Napoli","year":"2003","journal-title":"Stroke"},{"issue":"1","key":"10.1016\/j.sjbs.2014.05.003_b0095","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1166\/ajnn.2012.1042","article-title":"Spectrum from obesity to neurodegenerative disorder","volume":"4","author":"Diwan","year":"2012","journal-title":"Am. J. Neuroprotection Neuroregeneration"},{"key":"10.1016\/j.sjbs.2014.05.003_b0100","doi-asserted-by":"crossref","first-page":"241","DOI":"10.3233\/JAD-2008-13302","article-title":"An integrated and unifying hypothesis for the metabolic basis of sporadic Alzheimer\u2019s disease","volume":"13","author":"Erol","year":"2008","journal-title":"J. Alzheimers Dis."},{"issue":"5","key":"10.1016\/j.sjbs.2014.05.003_b0105","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1210\/er.2001-0039","article-title":"Oxidative stress and stress-activated signaling pathways: a unifying hypothesis of type 2 diabetes","volume":"23","author":"Evans","year":"2002","journal-title":"Endocrinol. Rev."},{"key":"10.1016\/j.sjbs.2014.05.003_b0110","doi-asserted-by":"crossref","first-page":"26055","DOI":"10.1016\/S0021-9258(19)74276-8","article-title":"Tumor necrosis factor-alpha suppresses insulin induced tyrosine phosphorylation of insulin receptor and its substrates","volume":"268","author":"Feinstein","year":"1993","journal-title":"J. Biol. Chem."},{"issue":"Suppl. 1","key":"10.1016\/j.sjbs.2014.05.003_b0115","doi-asserted-by":"crossref","first-page":"S43","DOI":"10.2337\/diabetes.53.2007.S43","article-title":"The biology of peroxisome proliferator-activated receptors: relationship with lipid metabolism and insulin sensitivity","volume":"53","author":"Ferre","year":"2004","journal-title":"Diabetes"},{"key":"10.1016\/j.sjbs.2014.05.003_b0120","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1016\/0304-3940(91)90490-K","article-title":"Elevated circulating tumor necrosis factor levels in Alzheimer\u2019s disease","volume":"129","author":"Fillit","year":"1991","journal-title":"Neurosci. Lett."},{"issue":"2","key":"10.1016\/j.sjbs.2014.05.003_b0125","doi-asserted-by":"crossref","first-page":"289","DOI":"10.2337\/dc07-1338","article-title":"Salsalate improves glycemia and inflammatory parameters in obese young adults","volume":"31","author":"Fleischman","year":"2008","journal-title":"Diabetes Care"},{"issue":"5","key":"10.1016\/j.sjbs.2014.05.003_b0130","doi-asserted-by":"crossref","first-page":"1596","DOI":"10.2337\/diabetes.51.5.1596","article-title":"C-reactive protein is an independent predictor of risk for the development of diabetes in the West of Scotland Coronary Prevention Study","volume":"51","author":"Freeman","year":"2002","journal-title":"Diabetes"},{"key":"10.1016\/j.sjbs.2014.05.003_b0135","doi-asserted-by":"crossref","first-page":"1752","DOI":"10.1172\/JCI21625","article-title":"Increased oxidative stress in obesity and its impact on metabolic syndrome","volume":"114","author":"Furukawa","year":"2004","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.sjbs.2014.05.003_b0140","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1016\/S0165-6147(02)02037-0","article-title":"Does insulin dysfunction play a role in Alzheimer\u2019s disease?","volume":"23","author":"Gasparini","year":"2002","journal-title":"Trends Pharmacol. Sci."},{"issue":"2","key":"10.1016\/j.sjbs.2014.05.003_b0145","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/j.neurobiolaging.2010.02.014","article-title":"Val(8)GLP-1 rescues synaptic plasticity and reduces dense core plaques in APP\/PS1 mice","volume":"33","author":"Gengler","year":"2012","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.sjbs.2014.05.003_b0150","doi-asserted-by":"crossref","first-page":"608","DOI":"10.1016\/S0006-291X(88)80538-2","article-title":"Amyloid fibrils formed from a segment of the pancreatic islet amyloid protein","volume":"155","author":"Glenner","year":"1988","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"4","key":"10.1016\/j.sjbs.2014.05.003_b0155","doi-asserted-by":"crossref","first-page":"809","DOI":"10.3233\/JAD-2009-0976","article-title":"Inflammation and NF-kappaB in Alzheimer\u2019s disease and diabetes","volume":"16","author":"Granic","year":"2009","journal-title":"J. Alzheimers Dis."},{"key":"10.1016\/j.sjbs.2014.05.003_b0160","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1111\/j.1750-3639.1998.tb00136.x","article-title":"Glial neuronal interactions in Alzheimer\u2019s disease: the potential role of a \u2018cytokine cycle\u2019 in disease progression","volume":"8","author":"Griffin","year":"1998","journal-title":"Brain Pathol."},{"issue":"2","key":"10.1016\/j.sjbs.2014.05.003_b0165","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1016\/j.pbb.2012.03.028","article-title":"Improvement in long term and visuo-spatial memory following chronic pioglitazone in mouse model of Alzheimer\u2019s disease","volume":"102","author":"Gupta","year":"2012","journal-title":"Pharmacol. Biochem. Behav."},{"issue":"3","key":"10.1016\/j.sjbs.2014.05.003_b0170","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1046\/j.1365-2265.2003.01767.x","article-title":"PPARgamma and metabolism: insights from the study of human genetic variants","volume":"59","author":"Gurnell","year":"2003","journal-title":"Clin. Endocrinol. (Oxf.)"},{"issue":"18","key":"10.1016\/j.sjbs.2014.05.003_b0175","doi-asserted-by":"crossref","first-page":"6862","DOI":"10.1523\/JNEUROSCI.20-18-06862.2000","article-title":"Peroxisome proliferator-activated receptor-gamma ligands reduce neuronal inducible nitric oxide synthase expression and cell death in vivo","volume":"20","author":"Heneka","year":"2000","journal-title":"J. Neurosci."},{"issue":"4","key":"10.1016\/j.sjbs.2014.05.003_b0180","doi-asserted-by":"crossref","first-page":"643","DOI":"10.2174\/157015911798376325","article-title":"Impact and therapeutic potential of PPARs in Alzheimer\u2019s disease","volume":"9","author":"Heneka","year":"2011","journal-title":"Curr. Neuropharmacol."},{"key":"10.1016\/j.sjbs.2014.05.003_b0185","doi-asserted-by":"crossref","first-page":"902","DOI":"10.1096\/fj.03-0978fje","article-title":"Diet-induced insulin resistance promotes amyloidosis in a transgenic mouse model of Alzheimer\u2019s disease","volume":"18","author":"Ho","year":"2004","journal-title":"FASEB J."},{"key":"10.1016\/j.sjbs.2014.05.003_b0190","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1126\/science.7678183","article-title":"Adipose expression of tumor necrosis factor-alpha: direct role in obesity-linked insulin resistance","volume":"259","author":"Hotamisligil","year":"1993","journal-title":"Science"},{"issue":"1","key":"10.1016\/j.sjbs.2014.05.003_b0195","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1186\/1471-2202-13-33","article-title":"Drugs developed to treat diabetes, liraglutide and lixisenatide, cross the blood brain barrier and enhance neurogenesis","volume":"13","author":"Hunter","year":"2012","journal-title":"BMC Neurosci."},{"issue":"5","key":"10.1016\/j.sjbs.2014.05.003_b0200","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1038\/nrn1387","article-title":"Neurovascular regulation in the normal brain and in Alzheimer\u2019s disease","volume":"5","author":"Iadecola","year":"2004","journal-title":"Nat. Rev. Neurosci."},{"key":"10.1016\/j.sjbs.2014.05.003_b0205","doi-asserted-by":"crossref","first-page":"1515","DOI":"10.1056\/NEJMoa010178","article-title":"Nonsteroidal anti-inflammatory drugs and the risk of Alzheimer\u2019s disease","volume":"345","author":"In\u2019t Veld","year":"2001","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.sjbs.2014.05.003_b0210","unstructured":"Inflammation: a unifying theory of disease? Research is showing that chronic inflammation may be the common factor in many diseases, 2006. Harvard Health Letter, 31(6), pp. 4\u20135."},{"key":"10.1016\/j.sjbs.2014.05.003_b0215","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1016\/j.neures.2006.04.008","article-title":"Glucagon-like peptide-1 inhibits LPS-induced IL-1beta production in cultured rat astrocytes","volume":"55","author":"Iwai","year":"2006","journal-title":"Neurosci. Res."},{"issue":"2","key":"10.1016\/j.sjbs.2014.05.003_b0220","doi-asserted-by":"crossref","first-page":"299","DOI":"10.2174\/18715273113126660145","article-title":"Alzheimer\u2019s and Type 2 diabetes management via common enzyme targeting","volume":"13","author":"Jabir","year":"2014","journal-title":"CNS Neurol. Disord. Drug Targets"},{"key":"10.1016\/j.sjbs.2014.05.003_b0225","first-page":"1","article-title":"Immunolocalization of islet amyloid polypeptide (IAPP) in pancreatic beta cells by means of peroxidase-antiperoxidase (PAP) and protein A-gold techniques","volume":"130","author":"Johnson","year":"1988","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.sjbs.2014.05.003_b0230","doi-asserted-by":"crossref","first-page":"2642","DOI":"10.1073\/pnas.94.6.2642","article-title":"Transcription factor NF-kappaB is activated in primary neurons by amyloid beta peptides and in neurons surrounding early plaques from patients with Alzheimer disease","volume":"94","author":"Kaltschmidt","year":"1997","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"12","key":"10.1016\/j.sjbs.2014.05.003_b0240","doi-asserted-by":"crossref","first-page":"2163","DOI":"10.1007\/s11064-009-0011-z","article-title":"Targeting BuChE-inflammatory pathway by SK0506 to manage type 2 diabetes and Alzheimer disease","volume":"34","author":"Kamal","year":"2009","journal-title":"Neurochem. Res."},{"key":"10.1016\/j.sjbs.2014.05.003_b0235","doi-asserted-by":"crossref","unstructured":"Kamal, M.A., Bellante, V., Greig, N.H., 2011. Butyrylcholinesterase inhibitors modulate cytokines production in peripheral blood mononuclear cells. Alzheimers Dementia: J. Alzheimers Assoc. 7(Suppl. 4), 671\u2013672.","DOI":"10.1016\/j.jalz.2011.05.1934"},{"issue":"2","key":"10.1016\/j.sjbs.2014.05.003_b0245","doi-asserted-by":"crossref","first-page":"338","DOI":"10.2174\/18715273113126660137","article-title":"Linking Alzheimer\u2019s disease and type 2 diabetes mellitus via aberrant insulin signaling and inflammation","volume":"13","author":"Kamal","year":"2014","journal-title":"CNS Neurol. Disord. Drug Targets"},{"key":"10.1016\/j.sjbs.2014.05.003_b0250","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1385\/JMN:18:1-2:07","article-title":"Interactions of glucagon-like peptide-1 (GLP-1) with the blood-brain barrier","volume":"18","author":"Kastin","year":"2002","journal-title":"J. Mol. Neurosci."},{"key":"10.1016\/j.sjbs.2014.05.003_b0255","doi-asserted-by":"crossref","unstructured":"Kiecolt-Glaser, J.K., Preacher, K.J., MacCallum, R.C., Atkinson, C., Malarkey, W.B., Glaser, R., 2003. Chronic stress and age-related increases in the proinflammatory cytokine IL-6. PNAS 100, 9090\u20139095.","DOI":"10.1073\/pnas.1531903100"},{"issue":"2","key":"10.1016\/j.sjbs.2014.05.003_b0260","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/S0304-3940(99)00055-5","article-title":"Activators of peroxisome proliferator-activated receptor-gamma (PPARgamma) inhibit inducible nitric oxide synthase expression but increase heme oxygenase-1 expression in rat glial cells","volume":"262","author":"Kitamura","year":"1999","journal-title":"Neurosci. Lett."},{"issue":"4","key":"10.1016\/j.sjbs.2014.05.003_b0265","doi-asserted-by":"crossref","first-page":"1532","DOI":"10.1210\/en.2009-1196","article-title":"Increased food intake leads to obesity and insulin resistance in the Tg2576 Alzheimer\u2019s disease mouse model","volume":"151","author":"Kohjima","year":"2010","journal-title":"Endocrinology"},{"key":"10.1016\/j.sjbs.2014.05.003_b0270","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1016\/j.nurt.2008.05.003","article-title":"PPAR gamma agonists as therapeutics for the treatment of Alzheimer\u2019s disease","volume":"5","author":"Landreth","year":"2008","journal-title":"Neurotherapeutics"},{"key":"10.1016\/j.sjbs.2014.05.003_b0275","doi-asserted-by":"crossref","unstructured":"Lehrer, S., 2014. Nasal NSAIDs for Alzheimer\u2019s disease. Am. J. Alzheimers Dis. Other Demen. <http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/?term=24413537>.","DOI":"10.1177\/1533317513518658"},{"key":"10.1016\/j.sjbs.2014.05.003_b0280","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1093\/oxfordjournals.aje.a009106","article-title":"Risk of dementia among persons with diabetes mellitus: a population-based cohort study","volume":"145","author":"Leibson","year":"1997","journal-title":"Am. J. Epidemiol."},{"issue":"7","key":"10.1016\/j.sjbs.2014.05.003_b0525","doi-asserted-by":"crossref","first-page":"1817","DOI":"10.2337\/db07-0171","article-title":"Alzheimer-like changes in rat models of spontaneous diabetes","volume":"56","author":"Li","year":"2007","journal-title":"Diabetes"},{"key":"10.1016\/j.sjbs.2014.05.003_b0285","doi-asserted-by":"crossref","first-page":"4617","DOI":"10.1074\/jbc.M411863200","article-title":"The hyperglycemia-induced inflammatory response in adipocytes: the role of reactive oxygen species","volume":"280","author":"Lin","year":"2005","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.sjbs.2014.05.003_b0290","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1002\/syn.20644","article-title":"Upregulation of RAGE at the blood-brain barrier in streptozotocin induced diabetic mice","volume":"63","author":"Liu","year":"2009","journal-title":"Synapse"},{"issue":"Pt. B","key":"10.1016\/j.sjbs.2014.05.003_b0295","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1016\/j.neulet.2013.10.052","article-title":"Glimepiride attenuates A\u03b2 production via suppressing BACE1 activity in cortical neurons","volume":"557","author":"Liu","year":"2013","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.sjbs.2014.05.003_b0300","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1038\/nrendo.2009.48","article-title":"Incretin-based therapies for type 2 diabetes mellitus","volume":"5","author":"Lovshin","year":"2009","journal-title":"Nat. Rev. Endocrinol."},{"issue":"17","key":"10.1016\/j.sjbs.2014.05.003_b0305","doi-asserted-by":"crossref","first-page":"6587","DOI":"10.1523\/JNEUROSCI.0529-11.2011","article-title":"The diabetes drug liraglutide prevents degenerative processes in a mouse model of Alzheimer\u2019s disease","volume":"31","author":"McClean","year":"2011","journal-title":"J. Neurosci."},{"key":"10.1016\/j.sjbs.2014.05.003_b0310","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/0165-0173(95)00011-9","article-title":"The inflammatory response system of brain: implications for therapy of Alzheimer and other neurodegenerative diseases","volume":"21","author":"McGeer","year":"1995","journal-title":"Brain Res. Brain Res. Rev."},{"issue":"6","key":"10.1016\/j.sjbs.2014.05.003_b0315","doi-asserted-by":"crossref","first-page":"2728","DOI":"10.1210\/jc.2003-032103","article-title":"Evidence for a potent antiinflammatory effect of rosiglitazone","volume":"89","author":"Mohanty","year":"2004","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"1","key":"10.1016\/j.sjbs.2014.05.003_b0320","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/j.neuroscience.2003.08.064","article-title":"Immunolocalization of peroxisome proliferator-activated receptors and retinoid X receptors in the adult rat CNS","volume":"123","author":"Moreno","year":"2004","journal-title":"Neuroscience"},{"key":"10.1016\/j.sjbs.2014.05.003_b0325","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1016\/S0166-2236(96)01035-1","article-title":"NF-kappa B: a crucial transcription factor for glial and neuronal cell function","volume":"20","author":"O\u2019Neill","year":"1997","journal-title":"Trends Neurosci."},{"key":"10.1016\/j.sjbs.2014.05.003_b0335","doi-asserted-by":"crossref","first-page":"1937","DOI":"10.1212\/WNL.53.9.1937","article-title":"Diabetes mellitus and the risk of dementia: the Rotterdam Study","volume":"53","author":"Ott","year":"1999","journal-title":"Neurology"},{"issue":"4","key":"10.1016\/j.sjbs.2014.05.003_b0340","doi-asserted-by":"crossref","first-page":"1256","DOI":"10.2337\/diabetes.51.4.1256","article-title":"Type 2 diabetes, APOE gene, and the risk for dementia and related pathologies: the Honolulu-Asia Aging Study","volume":"51","author":"Peila","year":"2002","journal-title":"Diabetes"},{"key":"10.1016\/j.sjbs.2014.05.003_b0345","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1677\/joe.0.1550219","article-title":"Studies of the mechanism of inhibition of insulin signaling by tumor necrosis factor-alpha","volume":"155","author":"Peraldi","year":"1997","journal-title":"J. Endocrinol."},{"key":"10.1016\/j.sjbs.2014.05.003_b0350","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1002\/jnr.10611","article-title":"Glucagon-like peptide-1 decreases endogenous amyloid-beta peptide (Abeta) levels and protects hippocampal neurons from death induced by Abeta and iron","volume":"72","author":"Perry","year":"2003","journal-title":"J. Neurosci. Res."},{"key":"10.1016\/j.sjbs.2014.05.003_b0355","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1016\/j.expneurol.2006.09.028","article-title":"Evidence of GLP-1-mediated neuroprotection in an animal model of pyridoxine-induced peripheral sensory neuropathy","volume":"203","author":"Perry","year":"2007","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.sjbs.2014.05.003_b0360","doi-asserted-by":"crossref","unstructured":"Pradhan, A.D., Manson, J.E., Rifai, N., Buring, J.E., Ridker, P.M., 2001. C-reactive protein, interleukin 6, and risk of developing type 2 diabetes mellitus. JAMA 286, 327\u2013334.","DOI":"10.1001\/jama.286.3.327"},{"issue":"4","key":"10.1016\/j.sjbs.2014.05.003_b0365","doi-asserted-by":"crossref","first-page":"482","DOI":"10.2174\/187152712800792767","article-title":"Alzheimer\u2019s disease and type 2 diabetes: exploring the association to obesity and tyrosine hydroxylase","volume":"11","author":"Priyadarshini","year":"2012","journal-title":"CNS Neurol. Disord. Drug Targets"},{"key":"10.1016\/j.sjbs.2014.05.003_b0370","first-page":"882","article-title":"Risk factors for dementia and Alzheimer\u2019s disease \u2013 findings from a community-based cohort study in Stockholm, Sweden","volume":"26","author":"Qiu","year":"2005","journal-title":"Zhonghua Liu Xing Bing Xue Za Zhi"},{"issue":"3","key":"10.1016\/j.sjbs.2014.05.003_b0375","doi-asserted-by":"crossref","first-page":"533","DOI":"10.2174\/18715273113126660167","article-title":"Current view from Alzheimer disease to type 2 diabetes mellitus","volume":"13","author":"Rasool","year":"2014","journal-title":"CNS Neurol. Disord. Drug Targets"},{"issue":"4","key":"10.1016\/j.sjbs.2014.05.003_b0385","doi-asserted-by":"crossref","first-page":"447","DOI":"10.2174\/156720512800492549","article-title":"Relationship between inflammatory mediators, A\u03b2 levels and APOE genotype in Alzheimer disease","volume":"9","author":"Reale","year":"2011","journal-title":"Curr. Alzheimer Res"},{"key":"10.1016\/j.sjbs.2014.05.003_b0380","doi-asserted-by":"crossref","unstructured":"Reale, M.A., Di Nicola, M., Velluto, L., D\u2019Angelo, C., Costantini, E., Lahiri, D., Kamal, M.A., Yu, Q.S., Grei, N.H., 2013. Selective acetyl- and butyrylcholinesterase inhibitors reduce amyloid-b ex vivo activation of peripheral chemo-cytokines from Alzheimer\u2019s disease subjects: exploring the cholinergic anti-inflammatory pathway. Curr. Alzheimer Res. 11 <http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/24359497>.","DOI":"10.2174\/1567205010666131212113218"},{"key":"10.1016\/j.sjbs.2014.05.003_b0390","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1038\/sj.tpj.6500369","article-title":"Efficacy of rosiglitazone in a genetically defined population with mild-to-moderate Alzheimer\u2019s disease","volume":"6","author":"Risner","year":"2006","journal-title":"Pharmacogenomics J."},{"key":"10.1016\/j.sjbs.2014.05.003_b0395","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1080\/02646830500382037","article-title":"Clinical aspects of inflammation in Alzheimer\u2019s disease","volume":"17","author":"Rosenberg","year":"2005","journal-title":"Int. Rev. Psychiatry"},{"issue":"9","key":"10.1016\/j.sjbs.2014.05.003_b0400","doi-asserted-by":"crossref","first-page":"1626","DOI":"10.1016\/j.neurobiolaging.2009.10.009","article-title":"Efficacy of PPAR-gamma agonist pioglitazone in mild Alzheimer disease","volume":"32","author":"Sato","year":"2009","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.sjbs.2014.05.003_b0405","doi-asserted-by":"crossref","first-page":"1649","DOI":"10.1016\/S0140-6736(99)01046-6","article-title":"Markers of inflammation and prediction of diabetes mellitus in adults (Atherosclerosis Risk in Communities study): a cohort study","volume":"353","author":"Schmidt","year":"1999","journal-title":"Lancet"},{"key":"10.1016\/j.sjbs.2014.05.003_b0410","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/S0896-6273(01)00475-5","article-title":"Clearing the brain\u2019s amyloid cobwebs","volume":"32","author":"Selkoe","year":"2001","journal-title":"Neuron"},{"key":"10.1016\/j.sjbs.2014.05.003_b0415","doi-asserted-by":"crossref","unstructured":"Seufert, J., Kieffer, T.J., Habener, J.F., 1999. Leptin inhibits insulin gene transcription and reverses hyperinsulinemia in leptin-deficient ob\/ob mice. PNAS 96(2), 674\u2013679.","DOI":"10.1073\/pnas.96.2.674"},{"key":"10.1016\/j.sjbs.2014.05.003_b0420","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/S0969-9961(03)00069-X","article-title":"Lipopolysaccharide-induced-neuroinflammation increases intracellular accumulation of amyloid precursor protein and amyloid beta peptide in APPswe transgenic mice","volume":"14","author":"Sheng","year":"2003","journal-title":"Neurobiol. Dis."},{"issue":"9","key":"10.1016\/j.sjbs.2014.05.003_b0425","doi-asserted-by":"crossref","first-page":"1482","DOI":"10.1111\/jgs.12415","article-title":"Angiotensin-converting enzyme inhibitors and Alzheimer\u2019s disease progression in older adults: results from the R\u00e9seau sur la Maladie d\u2019Alzheimer Fran\u00e7ais cohort","volume":"61","author":"Soto","year":"2013","journal-title":"J. Am. Geriatr. Soc."},{"issue":"1","key":"10.1016\/j.sjbs.2014.05.003_b0430","doi-asserted-by":"crossref","first-page":"63","DOI":"10.3233\/JAD-2005-7107","article-title":"Impaired insulin and insulin-like growth factor expression and signaling mechanisms in Alzheimer\u2019s disease-is this type 3 diabetes?","volume":"7","author":"Steen","year":"2005","journal-title":"J. Alzheimers Dis."},{"key":"10.1016\/j.sjbs.2014.05.003_b0435","doi-asserted-by":"crossref","first-page":"45","DOI":"10.3233\/JAD-2007-11108","article-title":"Rosiglitazone induces mitochondrial biogenesis in mouse brain","volume":"11","author":"Strum","year":"2007","journal-title":"J. Alzheimers Dis."},{"key":"10.1016\/j.sjbs.2014.05.003_b0440","doi-asserted-by":"crossref","first-page":"13287","DOI":"10.1073\/pnas.94.24.13287","article-title":"Two amyloid precursor protein transgenic mouse models with Alzheimer disease-like pathology","volume":"94","author":"Sturchler-Pierrat","year":"1997","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.sjbs.2014.05.003_b0445","doi-asserted-by":"crossref","first-page":"7036","DOI":"10.1073\/pnas.1000645107","article-title":"Diabetes accelerated memory dysfunction via cerebrovascular inflammation and A\u03b2 deposition in Alzheimer mouse model with diabetes","volume":"107","author":"Takeda","year":"2010","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"6","key":"10.1016\/j.sjbs.2014.05.003_b0450","doi-asserted-by":"crossref","first-page":"1822","DOI":"10.1039\/c0mb00302f","article-title":"Molecular mechanisms linking diabetes mellitus and Alzheimer disease: beta-amyloid peptide, insulin signaling, and neuronal function","volume":"7","author":"Takeda","year":"2011","journal-title":"Mol. Biosyst."},{"key":"10.1016\/j.sjbs.2014.05.003_b0455","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/0006-8993(96)00310-1","article-title":"Enhancement of immunoreactivity for NF-kappa B in the hippocampal formation and cerebral cortex of Alzheimer\u2019s disease","volume":"735","author":"Terai","year":"1996","journal-title":"Brain Res."},{"key":"10.1016\/j.sjbs.2014.05.003_b0460","doi-asserted-by":"crossref","first-page":"33305","DOI":"10.1074\/jbc.M610390200","article-title":"Soluble Abeta inhibits specific signal transduction cascades common to the insulin receptor pathway","volume":"282","author":"Townsend","year":"2007","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.sjbs.2014.05.003_b0465","doi-asserted-by":"crossref","first-page":"1156","DOI":"10.1212\/01.WNL.0000118210.12660.C2","article-title":"Dementia: the leading predictor of death in a defined elderly population: the Cache County study","volume":"62","author":"Tschantz","year":"2004","journal-title":"Neurology"},{"key":"10.1016\/j.sjbs.2014.05.003_b0470","doi-asserted-by":"crossref","first-page":"455","DOI":"10.2337\/diabetes.51.2.455","article-title":"High white blood cell count is associated with a worsening of insulin sensitivity and predicts the development of type 2 diabetes","volume":"51","author":"Vozarova","year":"2002","journal-title":"Diabetes"},{"issue":"12","key":"10.1016\/j.sjbs.2014.05.003_b0475","doi-asserted-by":"crossref","first-page":"1899","DOI":"10.1212\/01.WNL.0000065916.25128.25","article-title":"Insulin increases CSF Abeta42 levels in normal older adults","volume":"60","author":"Watson","year":"2003","journal-title":"Neurology"},{"issue":"11","key":"10.1016\/j.sjbs.2014.05.003_b0480","first-page":"950","article-title":"Preserved cognition in patients with early Alzheimer disease and amnestic mild cognitive impairment during treatment with rosiglitazone: a preliminary study","volume":"13","author":"Watson","year":"2005","journal-title":"Am. J. Geriatr. Psychiatry"},{"key":"10.1016\/j.sjbs.2014.05.003_b0485","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1146\/annurev.biochem.70.1.341","article-title":"Peroxisome proliferator-activated receptor gamma and metabolic disease","volume":"70","author":"Willson","year":"2001","journal-title":"Annu. Rev. Biochem."},{"key":"10.1016\/j.sjbs.2014.05.003_b0490","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1089\/dia.2010.0048","article-title":"Effect of exenatide on inflammatory and oxidative stress markers in patients with type 2 diabetes mellitus","volume":"13","author":"Wu","year":"2011","journal-title":"Diabetes Technol. Therapy"},{"key":"10.1016\/j.sjbs.2014.05.003_b0495","first-page":"1005","article-title":"Inflammation in Alzheimer disease: driving force, bystander or beneficial response?","volume":"12","author":"Wyss-Coray","year":"2006","journal-title":"Nat. Med."},{"key":"10.1016\/j.sjbs.2014.05.003_b0500","doi-asserted-by":"crossref","unstructured":"Xie, L., Helmerhorst, E., Taddei, K., Plewright, B., Van Bronswijk, W., Martins, R., 2002. Alzheimer\u2019s \u03b2-amyloid peptides compete for insulin binding to the insulin receptor. J. Neurosci. 22, RC221.","DOI":"10.1523\/JNEUROSCI.22-10-j0001.2002"},{"key":"10.1016\/j.sjbs.2014.05.003_b0505","doi-asserted-by":"crossref","first-page":"3877","DOI":"10.4049\/jimmunol.181.6.3877","article-title":"Cytokine-mediated inhibition of fibrillar amyloid beta peptide degradation by human mononuclear phagocytes","volume":"181","author":"Yamamoto","year":"2008","journal-title":"J. Immunol."},{"issue":"10","key":"10.1016\/j.sjbs.2014.05.003_b0510","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1212\/WNL.0b013e3182a35228","article-title":"Antihypertensive drugs decrease risk of Alzheimer disease: ginkgo evaluation of memory study","volume":"81","author":"Yasar","year":"2013","journal-title":"Neurology"},{"key":"10.1016\/j.sjbs.2014.05.003_b0515","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/S0006-8993(00)02970-X","article-title":"Human neurons generate C-reactive protein and amyloid P: upregulation in Alzheimer\u2019s disease","volume":"887","author":"Yasojima","year":"2000","journal-title":"Brain Res."},{"key":"10.1016\/j.sjbs.2014.05.003_b0520","doi-asserted-by":"crossref","first-page":"880","DOI":"10.1212\/WNL.59.6.880","article-title":"Reduced incidence of AD with NSAID but not H2 receptor antagonists: the Cache County study","volume":"59","author":"Zandi","year":"2002","journal-title":"Neurology"}],"container-title":["Saudi Journal of Biological Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1319562X14000424?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1319562X14000424?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,4,4]],"date-time":"2022-04-04T02:14:27Z","timestamp":1649038467000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1319562X14000424"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,1]]},"references-count":105,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2015,1]]}},"alternative-id":["S1319562X14000424"],"URL":"https:\/\/doi.org\/10.1016\/j.sjbs.2014.05.003","relation":{},"ISSN":["1319-562X"],"issn-type":[{"value":"1319-562X","type":"print"}],"subject":[],"published":{"date-parts":[[2015,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Alzheimer\u2019s disease and type 2 diabetes via chronic inflammatory mechanisms","name":"articletitle","label":"Article Title"},{"value":"Saudi Journal of Biological Sciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.sjbs.2014.05.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 Production and hosting by Elsevier B.V.","name":"copyright","label":"Copyright"}]}}